Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines

• Walderik W. Zomerman,

  Affiliation Department of Pediatric Oncology/Hematology, Beatrix Children’s Hospital, University Medical Center Groningen, Groningen, The Netherlands

  ⨯
• Sabine L. A. Plasschaert ,

  * E-mail: splasschaert@prinsesmaximacentrum.nl

  Affiliations Department of Pediatric Oncology/Hematology, Beatrix Children’s Hospital, University Medical Center Groningen, Groningen, The Netherlands, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands

  ⨯
• Sander H. Diks,

  Affiliation Department of Pediatric Oncology/Hematology, Beatrix Children’s Hospital, University Medical Center Groningen, Groningen, The Netherlands

  ⨯
• Harm-Jan Lourens,

  Affiliation Department of Pediatric Oncology/Hematology, Beatrix Children’s Hospital, University Medical Center Groningen, Groningen, The Netherlands

  ⨯
• Tiny Meeuwsen-de Boer,

  Affiliation Department of Pediatric Oncology/Hematology, Beatrix Children’s Hospital, University Medical Center Groningen, Groningen, The Netherlands

  ⨯
• Eelco W. Hoving,

  Affiliation Department of Neurosurgery, University Medical Center Groningen, Groningen, The Netherlands

  ⨯
• Wilfred F. A. den Dunnen,

  Affiliation Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands

  ⨯
• Eveline S. J. M. de Bont

  Affiliation Department of Pediatric Oncology/Hematology, Beatrix Children’s Hospital, University Medical Center Groningen, Groningen, The Netherlands

  ⨯